Current status of Duchenne muscular dystrophy

Research output: Contribution to journalArticlepeer-review

22 Scopus citations


Duchenne muscular dystrophy is the second most common lethal genetic disorder in humans. With the advent of molecular genetic technology, the definition of this disease has been modified to include an abnormality of dystrophin in muscle-a dystrophinopathy. Accurate genetic counseling is possible using methods of deletion detection and linkage analysis. Treatment of this type of muscular dystrophy may soon mean the routine use of steroids and later include direct injection of an artificial gene for dystrophin.

Original languageEnglish (US)
Pages (from-to)879-894
Number of pages16
JournalPediatric clinics of North America
Issue number4
StatePublished - 1992

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health


Dive into the research topics of 'Current status of Duchenne muscular dystrophy'. Together they form a unique fingerprint.

Cite this